U.S. Professional Services Stock News

Recent share performance and business snapshot Columbia Financial (CLBK) has drawn investor attention after a period of solid stock performance, with the share price at $20.70 and total return around 49% over the past year. For context, the bank holding company reports annual revenue of about $259.2 million and net income of $55.97 million, with both revenue and profit showing positive annual growth rates based on the latest figures provided. The stock’s gains of about 6% over the past month...

Investors may be considering whether W.W. Grainger at around US$1,315 per share still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 1.2% over the last week, 3.4% over the last month, 31.1% year to date and 24.7% over the past year, which can change how investors think about both its potential and its risks. Recent coverage has focused on W.W. Grainger's role in industrial distribution and how it is positioning its operations and customer...

We wouldn't blame NRC Health ( NASDAQ:NRC ) shareholders if they were a little worried about the fact that Michael...

Earlier in June 2026, Alvotech reported that the FDA accepted its Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio for intravenous use, while also resubmitting BLAs for AVT05 and AVT06 after enhancing its Reykjavik manufacturing facility and addressing regulatory observations. These regulatory milestones highlight Alvotech’s expanding biosimilar pipeline in immunology and ophthalmology and indicate progress in strengthening its quality systems under...

With war in Iran disrupting oil supplies, energy prices jumping and inflation back at a three year high, the mood in markets has shifted fast. Higher U.S. Treasury yields and talk of fresh Federal Reserve rate hikes are putting pressure on richly priced growth stories, while investors pay closer attention to cash flow and balance sheet strength. Dividend growth stocks with solid financial footing can look appealing in this kind of backdrop, but not all are affected in the same way. This...

Fresh IPOs are back in the spotlight, with the record SpaceX listing, a 19.2% first day surge, talk of Middle East peace helping crude oil prices, and stronger consumer sentiment all hitting the market at once. At the same time, stubborn inflation and a Federal Reserve that looks set to hold rates steady keep a lid on the easy-money story. Against this mix, some newly listed stocks have started to stand out. This article highlights 3 recent IPOs from the IPO Momentum Stocks screener. These...

Kennedy-Wilson Holdings (KW) has attracted fresh attention after recent trading, with the stock last closing at $10.93. For investors, that price stands in the context of mixed recent returns and sizeable exposure to global real estate. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been relatively muted, with a 1 day share price return of 0.09% and a 30 day share price return of 0.91%. However, a 13.38% year to date share price return sits alongside a 1 year total...

Some The J. M. Smucker Company ( NYSE:SJM ) shareholders may be a little concerned to see that the Chief Legal Officer...

Some Gen Digital Inc. ( NASDAQ:GEN ) shareholders may be a little concerned to see that the Director, Ondrej Vlcek...

Why Clear Channel Outdoor Holdings is on investors’ radar today Clear Channel Outdoor Holdings (CCO) has drawn investor attention after recent trading reflected modest short term gains, prompting closer scrutiny of how its current valuation lines up with its fundamentals and risk profile. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.41, Clear Channel Outdoor Holdings has seen steady share price momentum, with a 13.68% year to date share price return and a...

Recent commentary on TransDigm Group highlights that its core aircraft components business has delivered strong organic revenue growth, expanding profitability, and robust free cash flow generation, underpinned by high-margin aftermarket sales of mission-critical parts. An interesting nuance is that this operational strength coexists with recent insider share sales, suggesting executives are realizing gains even as external assessments still score the company highly on profitability and...

On June 2, 2026, Pebblebrook Hotel Trust amended its Maryland Declaration to allow shareholders to remove trustees without cause, following prior shareholder approval. This governance change, alongside recent insider share purchases amid revised 2026 net income guidance and a US$19.27 million Q1 net loss on US$345.66 million in revenue, has become a focal point for investors reassessing the REIT’s risk–reward profile. We’ll now examine how the expanded right to remove trustees without cause...

The recent 17% drop in CervoMed Inc.'s ( NASDAQ:CRVO ) stock could come as a blow to insiders who purchased US$455.1k...

We wouldn't blame Centene Corporation ( NYSE:CNC ) shareholders if they were a little worried about the fact that...

A sharp rise in call options trading on CF Industries Holdings (CF), along with debate over whether the stock looks undervalued on several metrics, has pulled fresh investor focus to this nitrogen producer. See our latest analysis for CF Industries Holdings. CF’s share price has pulled back recently, with a 30 day share price return of down 12.6% and a 90 day share price return of down 10.5%. However, year to date the share price return is up 36.6% and the 5 year total shareholder return is...

SpaceX’s record US$75b IPO and US$2t market cap have grabbed headlines, but the ripple effects may matter more for you as an investor. Fresh enthusiasm for mega-IPOs and high-growth stories is colliding with questions about rich valuations and business risk. That mix of optimism and caution is now spilling over into other recently listed large caps that could one day qualify for major indices. This article highlights 3 stocks from our Index Inclusion Beneficiaries screener that are especially...

Green Brick Partners (GRBK) is back in focus after recent U.S. housing legislation moved forward that restricts institutional investors from buying single family homes, drawing fresh attention to the homebuilder’s position in this shifting policy backdrop. See our latest analysis for Green Brick Partners. Recent news around the revised U.S. housing bill, Green Brick’s role as a core Greenlight Capital holding, and a new chief accounting officer appointment has coincided with a 16.44% 1 month...

BrightSpring Health Services (BTSG) has drawn fresh investor attention after analysts highlighted the stock with strong ratings and Goldman Sachs initiated coverage, alongside the appointment of AI-focused physician Dr. Nigam H. Shah to the Board. See our latest analysis for BrightSpring Health Services. Recent activity reflects that shift in sentiment, with the share price at US$63.23 and strong momentum, including a 90 day share price return of 61.92% and a 1 year total shareholder return...

Global Partners (GLP) caught investor attention after reporting first quarter 2026 earnings per unit of $1.85, topping analyst expectations, while inflation and volatile energy markets have put fresh focus on its fuel distribution network. See our latest analysis for Global Partners. Despite the strong earnings surprise, the recent share price has slipped, with a 1-day share price return of 5.06% down and a 7-day share price return of 4.03% down, even as the year to date share price return of...

Colgate-Palmolive recently declared a quarterly cash dividend of US$0.53 per common share, payable on August 14, 2026, to shareholders of record on July 20, 2026, while reporting broad-based first-quarter 2026 growth in net sales, organic sales, profitability, and free cash flow. These results, alongside uninterrupted dividends since 1895 and 36 consecutive annual increases, underscore Colgate-Palmolive’s emphasis on consistent cash returns and operational improvement across its oral care,...

Structure Therapeutics (GPCR) drew attention after publishing Phase 2b ACCESS trial data for its oral GLP-1 candidate aleniglipron in Nature Medicine, alongside a detailed presentation at the American Diabetes Association’s 86th Scientific Sessions. See our latest analysis for Structure Therapeutics. The latest data release has arrived against a mixed price backdrop, with the stock at US$42.93 after a strong 7 day share price return of 14.24%. This contrasts with a weaker 90 day share price...

Why Matson’s latest earnings report matters for shareholders Matson (MATX) recently reported quarterly results that paired a revenue shortfall with operating income ahead of expectations, putting the spotlight on how its key shipping and logistics businesses are currently performing. See our latest analysis for Matson. The earnings beat on operating income appears to have reinforced confidence in Matson’s core shipping franchise, with a 90 day share price return of 33.44% and a 1 year total...

Earlier this week, Tidewater Inc. reaffirmed its FY 2026 revenue guidance of US$1.43 billion to US$1.48 billion and a gross margin outlook of 49% to 51%, contingent on closing the Wilson Sons acquisition by the end of the second quarter. This update underlined how higher vessel utilization, stronger day rates and expanding margins are supporting management’s confidence in both earnings quality and the Wilson Sons deal. We’ll now examine how Tidewater’s reaffirmed revenue and margin guidance,...

Recent price performance and business mix Icahn Enterprises (IEP) has seen its unit price decline about 10% over the past month and about 5% over the past 3 months, drawing attention to how its diversified operations are currently valued. The partnership spans multiple businesses, including investment funds, energy refining and renewables, automotive services and parts, food packaging, real estate, home fashion and pharma. As a result, the stock reflects a mix of cyclical and defensive...